Hello, Guest!
  • Friday, April 26, 2024

Watch Stan Sloane at SRA Investor Day

SRA International, Inc. (NYSE: SRX) hosted an Investor and Analyst Day at the New York Stock Exchange.

According to the firm, “SRA President and CEO Stan Sloane along with other SRA executives provided a detailed overview of the company and an update on its growth strategy, competitive environment and financial performance. The presentation and web cast archive will be available at www.sra.com/investors/.”

Video of the Day

Related Articles

Ex-SRA Intl CEO Stan Sloane Joins Decision Sciences Intl as CEO, Will Move HQ to Virginia Executive Moves

Ex-SRA Intl CEO Stan Sloane Joins Decision Sciences Intl as CEO, Will Move HQ to Virginia

Former SRA International CEO Stan Sloane has been named president and CEO of Decision Sciences International, a private company that produces nuclear detection systems for cargo screening. Previous Decision head Robert Whalen now runs the firm’s development business unit. Prior to joining SRA in April 2007, Sloane led Lockheed Martin‘s (NYSE: LMT) $5 billion integrated systems and

SRA CEO Stan Sloane Discusses New Health & Civil Services Sector Lead Executive Moves

SRA CEO Stan Sloane Discusses New Health & Civil Services Sector Lead

SRA International, Inc. (NYSE: SRX) named Stephen Tolbert to the post of senior vice president of Health and Civil Services (HCS) Sector. Reporting to SRA president and CEO Stan Sloane, Tolbert will be responsible “for leading all business development and program execution across federal civilian agencies.” “Steve has been a key contributor and solid leader

SRA Fiscal Numbers Show Strong Growth; Stan Sloane Comments News

SRA Fiscal Numbers Show Strong Growth; Stan Sloane Comments

SRA International (NYSE: SRX) reported estimate-beating growth in both earnings per share and revenues. The firm reported the following: “Net income increased to $20.9 million or $0.36 per share from $17.48 million or $0.30 per share a year ago.  Excluding special items, adjusted income would have been $21.15 million or $0.36 per share for the